{
    "N/R/U": null,
    "Applicant": "Juno Therapeutics, Inc. a Bristol Myer-Squibb Company",
    "BLA Number": "125714",
    "Proprietary Name": "Breyanzi",
    "Proper Name": "lisocabtagene maraleucel",
    "BLA Type": "351(a)",
    "Strength": "4.6ML/VIAL",
    "Dosage Form": "Injection",
    "Route of Administration": "Intravenous",
    "Product Presentation": "Single-Dose Vial",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "February 05, 2021",
    "Ref. Product Proper Name": " ",
    "Ref. Product Proprietary Name": " ",
    "Supplement Number": "0",
    "Submission Type": "Original",
    "License Number": "2156",
    "Product Number": "001",
    "Center": "CBER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": "May 30, 2031"
}